natgillin/translations-raw huggingface dataset:
This medicinal product is contraindicated in the following cases: 
To zdravilo je kontraindicirano v naslednjih primerih:
However, reduced alertness may also be of concern when participating in road traffic. 
Vendar je lahko zmanjšana pozornost pomembna tudi pri udeležbi v cestnem prometu.
After first opening 30 days. 
Po prvem odprtju 30 dni.
The medicine should be given at the same time each day. 
Zdravilo je treba dajati vsak dan ob istem času.
Tel: + 33 (0)1 58 28 16 80 Fax: + 33 (0)1 58 28 16 90 
Tel. št.: + 33 (0)1 58 28 16 80 Faks: + 33 (0)1 58 28 16 90
Those not already mentioned above, which could happen in children as well are listed below. 
Tisti, ki niso omenjeni zgoraj in ki se lahko pojavijo tudi pri otrocih, so navedeni v nadaljevanju.
For first use 1. 
Za prvo uporabo 1.
It is administered directly into the child's mouth. 
Daje se neposredno v otrokova usta.
In very rare cases, an intolerance to alcohol may occur. 
V redkih primerih se lahko pojavi intoleranca na alkohol.
In all cases, HbA1c must be monitored every three months. 
V vseh primerih je treba raven HbA1c preverjati vsake tri mesece.
- excessive hunger, headache 
- prekomerna lakota, glavobol
− in patients with porphyria; 
− pri bolnikih s porfirijo;
(In rare cases, it has taken 4 months to wean off insulin completely). 
(V redkih primerih so bili za popolno prenehanje zdravljenja z insulinom potrebni 4 meseci).
Glibenclamide should not be given during pregnancy. 
Glibenklamid se ne sme dajati med nosečnostjo.
The plasma glibenclamide levels in the simulated paediatric population were approximately 30%-60% lower than the adult levels. 
Ravni glibenklamida v plazmi v simulirani pediatrični populaciji so bile za približno 30 %-60 % nižje od ravni pri odraslih.
It should therefore not be prescribed for these patients, and the use of an alternative treatment is strongly recommended, if available. 
Zato se takim bolnikom ne bi smel predpisovati in, če je na voljo, se močno priporoča uporaba drugačnega zdravljenja.
This medicine is not intended to be used in pregnant women and patients planning a pregnancy should inform their doctor. 
To zdravilo ni namenjeno uporabi pri nosečnicah, bolnice, ki načrtujejo nosečnost, pa se morajo posvetovati z zdravnikom.
Kidney failure does not affect its elimination as long as creatinine clearance remains above 30 ml/min. 
Odpoved ledvic ne vpliva na njegovo izločanje, dokler je očistek kreatinina večji od 30 ml/min.
General aspects 
Splošni vidiki
Incorrect control of plasma sugar (see section 2 “Do not give AMGLIDIA”) 
Nepravilen nadzor sladkorja v plazmi (glejte poglavje 2 „Ne dajajte zdravila AMGLIDIA“)
Healthcare professionals or patients should never use another syringe than the one provided in the box to avoid dosing errors which could result in serious harm. 
Zdravstveni delavci ali bolniki ne smejo nikoli uporabiti druge brizge razen tiste, ki je priložena v škatli, da se preprečijo napake pri odmerjanju, ki bi lahko povzročile resno škodo.
Centre Spécialités Pharmaceutiques 76-78 Avenue du midi 63800 Cournon d'Auvergne France 
Centre Spécialités Pharmaceutiques 76-78 Avenue du midi 63800 Cournon d'Auvergne Francija
Always give the medicine before feeding, 
Zdravilo vedno dajte pred hranjenjem.
Overall, the safety profile of Glibenclamide is in line with the safety profile of others sulfonylureas. 
Na splošno je varnostni profil glibenklamida skladen z varnostnim profilom drugih sulfonilsečnin.
- Increase in sensitivity of the skin to sunlight. 
- večja občutljivost kože na svetlobo;
Frequencies are defined as: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000), not known (cannot be estimated from the available data). 
Pogostnost je opredeljena kot: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1 000 do < 1/100), redki (≥ 1/10 000 do < 1/1 000), zelo redki (< 1/10 000), neznana pogostnost (ni mogoče oceniti iz razpoložljivih podatkov).
Adolescents are not in need of this oral suspension formulation. 
Mladostnikom ni treba jemati te formulacije (peroralne suspenzije).
Concomitant use of alcohol and glibenclamide should be avoided. 
Sočasni uporabi alkohola in glibenklamida se je treba izogibati.
If there is no alternative, the decision for each patient must consider the danger of haemolysis and the potential benefit expected from the treatment. 
Če ni alternative, je treba pri sprejemanju odločitve za posameznega bolnika upoštevati nevarnost hemolize in morebitne pričakovane koristi zdravljenja.
It should be ensured that the proper dose and strength are communicated and dispensed. 
Zagotoviti je treba, da se sporočita in izdata ustrezen odmerek in jakost.
This medicine may cause allergic reactions, which may be serious in isolated cases, including difficulties to breath, low blood pressure and shock. 
To zdravilo lahko povzroči alergijske reakcije, ki so lahko v posameznih primerih resne ter lahko vključujejo oteženo dihanje, nizek krvni tlak in šok.
Patients occasionally may have very high glucose values, i.e. > 20 mmol/L (> 360 mg/dL). 
Občasno imajo lahko bolniki zelo velike vrednosti glukoze, tj. > 20 mmol/l (> 360 mg/dl).
Patients must be closely monitored for at least 48 hours and, depending on the patient's condition at this time, the physician will decide if additional monitoring is necessary. 
Bolnike je treba skrbno spremljati vsaj 48 ur, nato pa se zdravnik glede na bolnikovo stanje odloči, ali je potrebno nadaljnje spremljanje.
It is recommended to wait for the child has swallowed the medicine before reverting back to lying position. 
Priporočljivo je, da počakate, da otrok pogoltne zdravilo, preden se vrne nazaj v ležeči položaj.
Tell your doctor or pharmacist if your child is taking, has recently taken or might take any other medicines. 
Obvestite zdravnika ali farmacevta, če vaš otrok jemlje, je pred kratkim jemal ali pa bo morda začel jemati katero koli drugo zdravilo.
If your child presents any of theses symptoms, you should immediately go to the nearest emergency department. 
Če se pri vašem otroku pojavi kateri koli od teh simptomov, takoj obiščite najbližji urgentni oddelek.
A summary of the interactions detailed above and further interactions are summarised in the table below. 
Povzetek zgoraj podrobneje opisanih medsebojnih delovanj in druga medsebojna delovanja so povzeta v spodnji tabeli.
Patients or their caretakers should be reminded to use the correct syringe as stated in their prescription. 
Bolnike ali skrbnike je treba opozoriti, naj uporabijo ustrezno brizgo, kot je navedeno na njihovem receptu.
Do not give a double dose to make up for a forgotten dose. 
Ne dajajte dvojnega odmerka, če ste pozabili dati prejšnji odmerek.
After first opening, use within 30 days. 
Po prvem odprtju uporabite v 30 dneh.
Make sure that you use correct strength of the medicine and the appropriate oral syringe prescribed by your doctor to avoid accidental administration of too high or too low amounts. 
Prepričajte se, da uporabljate ustrezno jakost zdravila in ustrezno peroralno brizgo, ki jo je predpisal zdravnik, da preprečite nenamerno zaužitje prevelikih ali premajhnih količin.
Ask your doctor to determine at which frequency capillary blood sugar should be checked. 
Prosite zdravnika, naj določi, kako pogosto bi bilo treba preverjati sladkor v kapilarni krvi.
It is important you do not adjust yourself the doses of either AMGLIDIA or insulin, unless specifically directed to do so by your child's doctor. 
Pomembno je, da sami ne prilagajate odmerkov zdravila AMGLIDIA ali insulina, razen če vam to izrecno naroči zdravnik vašega otroka.
Ciclosporin used to prevent rejection of the transplanted organ 
Ciklosporin, ki se uporablja za preprečevanje zavrnitve presajenega organa
The minimum active concentration for the effect is considered to be 30-50 ng/mL glibenclamide. 
Šteje se, da je najmanjša aktivna koncentracija za ta učinek 30-50 ng/ml glibenklamida.
The glycosylated haemoglobin level should be measured every three months to assess the child's metabolic equilibrium. 
Raven glikoziliranega hemoglobina je treba meriti vsake tri mesece, da se oceni otrokovo metabolično ravnovesje.
Then push the plunger to remove as many air bubbles as possible from the syringe (figure 4B). 
Nato potisnite bat, da iz brizge odstranite čim več zračnih mehurčkov (slika 4B).
Note: if air gets into the syringe, empty the syringe into the bottle and start the procedure again. 
Opomba: Če pride zrak v brizgo, jo izpraznite v steklenico in ponovite postopek.
- if your child is allergic to glibenclamide or any of the other ingredients of this medicine (listed in section 6). 
- če je vaš otrok alergičen na glibenklamid ali katero koli sestavino tega zdravila (navedeno v poglavju 6);
− hypersensitivity to the active substance, other sulphonylureas or sulphonamides or to any of the excipients listed in section 6.1; 
− pri preobčutljivosti za učinkovino, druge sulfonilsečnine ali sulfonamide ali katero koli od pomožnih snovi, navedenih v poglavju 6.1;
The risk of low blood sugar is increased if the medicine is not taken with a meal, is taken with alcohol, or if combined with certain medicines. 
Tveganje za nizke ravni sladkorja v krvi se poveča, če se zdravilo ne jemlje med obrokom, se jemlje skupaj z alkoholom ali v kombinaciji z nekaterimi zdravili.
Safety and efficacy of Amglidia in elderly patients has not been established since the medicinal product is indicated in the paediatric population. 
Varnost in učinkovitost zdravila AMGLIDIA pri starejših bolnikih nista bili dokazani, saj je zdravilo indicirano pri pediatrični populaciji.
• If the patient is prescribed a different presentation, the prescriber should highlight to the patient the packaging differences between the different presentations (focus on colour differentiation, warning statements on carton, thickness and length of the provided syringe). 
• Če se bolniku predpiše druga oblika zdravila, mora zdravnik, ki predpiše zdravilo, bolniku pojasniti razlike v pakiranju med različnimi oblikami zdravila (pri tem se mora osredotočiti na razlikovanje barv, opozorilne izjave na škatli ter debelino in dolžino priložene brizge).
After oral administration, glibenclamide is absorbed rapidly and induces its effect within 2.5 hours with a duration of up to 15 hours, although the elimination half-life is 5 to 10 hours. 
Po peroralni uporabi se glibenklamid hitro absorbira in začne učinkovati v 2,5 ure, njegov učinek pa traja do 15 ur, čeprav je razpolovni čas izločanja 5 do 10 ur.
Based on a limited amount of published data, the use of glibenclamide during the 1st trimester does not seem to cause an increase in congenital malformations. 
Na podlagi omejene količine objavljenih podatkov se zdi, da uporaba glibenklamida v prvem trimesečju ne povzroča povečanja kongenitalnih malformacij.
If no improvement is seen (unchanged insulin dose, similar glycaemic control and no improvement in neurology), AMGLIDIA should be discontinued. 
Če ni videti izboljšanja (nespremenjen odmerek insulina, podoben glikemični nadzor in odsotnost nevrološkega izboljšanja), je treba zdravilo AMGLIDIA prekiniti.
The nearest volume to the calculated one should be used. 
Uporabiti je treba volumen, ki je najbliže izračunanemu volumnu.
− in patients taking bosentan (see section 4.5) 
− pri bolnikih, ki jemljejo bosentan (glejte poglavje 4.5);
Two cases of severe hypoglycaemia were observed, which were considered related to the medicinal product. 
Ugotovljena sta bila dva primera hude hipoglikemije, za katera se smatra, da sta povezana z zdravilom.
With respect to the 2nd and 3rd trimester published data did not find fetotoxic effects. 
Kar zadeva drugo in tretje trimesečje, objavljeni podatki ne kažejo fetotoksičnih učinkov.
With smaller bodyweight the concentration increased but exceeded the adult plasma levels in minimal extents only for poor metabolizers. 
Pri manjši telesni masi se je koncentracija povečala, vendar je minimalno presegla ravni v plazmi pri odraslih le pri slabih presnavljalcih.
For patients still under insulin at day 6, maintain the dose of AMGLIDIA for at least 4 weeks. 
Pri bolnikih, ki 6. dan še vedno uporabljajo insulin, vdržujte odmerek zdravila AMGLIDIA vsaj 4 tedne.
After enrolment, patients continued taking their usual doses of glibenclamide tablets for 1 month. 
Po vključitvi v študijo so bolniki en mesec nadaljevali jemanje običajnih odmerkov tablet glibenklamida.
Glibenclamide may increase the risk of low blood sugar and therefore have a moderate influence on the ability to drive, to take part in road traffic otherwise or use machines. 
Glibenklamid lahko poveča tveganje za nizke ravni sladkorja v krvi, zato ima zmeren vpliv na sposobnost vožnje, kakršno koli drugo udeležbo v cestnem prometu ali upravljanje strojev.
The conversion rate between micronised tablets and the suspension has not been established. 
Stopnja pretvorbe med mikroniziranimi tabletami in suspenzijo ni bila ugotovljena.
The average dose reported in the literature (clinical trials and case reports) is of approximately 0.5 mg/kg/day. 
Povprečni odmerek, o katerem so poročali v literaturi (kliničnih preskušanjih in poročilih o primerih), je približno 0,5 mg/kg/dan.
Severe hypoglycaemic reactions, with coma, convulsions or other neurological disorders are possible and are medical emergencies requiring immediate treatment as soon as the cause is diagnosed or suspected before immediately admitting the patient to hospital. 
Možne so hude hipoglikemične reakcije s komo, konvulzijami ali drugimi nevrološkimi motnjami, ki so nujni zdravstveni primeri, ki zahtevajo takojšnje zdravljenje, kakor hitro se diagnosticira vzrok ali se sumi nanj, preden se bolnika nemudoma sprejme v bolnišnico.
These values were approx. 40% greater than those obtained for the crushed tablet (148.34 ± 46.74 ng/mL). 
Te vrednosti so bile za približno 40 % višje od vrednosti, dobljenih za zdrobljene tablete (148,34 ± 46,74 ng/ml).
Benzoate salt may increase jaundice (yellowing of the skin and eyes) in newborns (up to 4 weeks old). 
Benzoatna sol lahko poveča tveganje za zlatenico (rumeno obarvanje kože in oči) pri novorojenčkih (do 4. tedna starosti).
Glibenclamide is completely metabolised by the liver into 3 inactive metabolites excreted via bile (60%) and urine (40%); elimination is complete in 45 to 72 hours. 
V jetrih se glibenklamid v celoti presnovi v 3 neaktivne presnovke, ki se izločijo prek žolča (60 %) in urina (40 %); izločanje je končano v 45 do 72 urah.
This was a phase II, single-centre, prospective, open-label, non-randomised study. 
To je bila enocentrična, prospektivna, odprta, nerandomizirana študija druge faze.
Once steady state is reached, capillary blood glucose does no longer need to be daily monitored except in clinical situations at risk of metabolic unbalance (see below). 
Ko se doseže stanje dinamičnega ravnovesja, ravni glukoze v kapilarni krvi ni treba več spremljati vsak dan, razen v kliničnih situacijah s tveganjem presnovnega neravnovesja (glejte spodaj).
Anabolic steroids and male sex hormones 
Anabolni steroidi in moški spolni hormoni
As the dose is increased, it is usually possible to reduce and then stop the dose of insulin the patient is already receiving. 
Ker se odmerek povečuje, je običajno mogoče zmanjšati in nato ukiniti odmerek insulina, ki ga bolnik že prejema.
1 x 30 mL bottle. 
1 x 30 ml steklenica
Glibenclamide is strongly bound to plasma albumin (99%), which may account for certain drug interactions, but is not easily detached by acidic medicinal products. 
Glibenklamid se močno veže na albumin v plazmi (99 %), kar je lahko vzrok za nekatera medsebojna delovanja zdravil, vendar ga ni mogoče enostavno izločiti s kislimi zdravili.
Special care should be taken when calculating the dose. 
Pri izračunavanju odmerka je potrebna posebna previdnost.
If ketone bodies are present, an insulin injection must be given rapidly to restore the metabolic situation. 
Če so prisotna ketonska telesa, je treba hitro injicirati insulin, da se ponovno vzpostavi ustrezno metabolično stanje.
Contains sodium and benzoate, see leaflet for further information. 
Vsebuje natrij in benzoat, za več informacij glejte navodilo za uporabo.
Since no interaction study between glibenclamide and milk has been performed, and despite absence of food effect on glibenclamide absorption, recommendation is given to administer the suspension 15 minutes before child's milk feeding. 
Ker ni bila izvedena nobena študija o medsebojnem delovanju glibenklamida in mleka in čeprav hrana ne vpliva na absorpcijo glibenklamida, se priporoča dajanje suspenzije 15 minut pred hranjenjem otroka z mlekom.
In case of milk feeding, recommendation is given to administer the suspension 15 minutes before child's milk feeding. 
Če se otrok hrani z mlekom, se priporoča dajanje suspenzije 15 minut pred hranjenjem otroka z mlekom.
In some cases these high glucose values seem to settle with the normal dose of AMGLIDIA. 
V nekaterih primerih je videti, da se te velike vrednosti glukoze uravnovesijo ob normalnem odmerku zdravila AMGLIDIA.
Due to strong binding of glibenclamide to proteins, dialysis is of no benefit to the patient. 
Ker se glibenklamid močno veže na beljakovine, dializa bolniku ne koristi.
Clinical studies appear to suggest that CYP2C9 contributes significantly to glibenclamide metabolism in vivo. 
Klinične študije kažejo, da CYP2C9 znatno prispeva k presnovi glibenklamida in vivo.
Blood affections generally reversible when treatment stops. 
Krvna obolenja so običajno reverzibilna po prenehanju zdravljenja.
The Prescriber's Guide shall contain the following key messages: 
Vodnik za zdravnike, ki predpisujejo zdravilo, vsebuje naslednja ključna sporočila:
This medicine is an oral suspension, to be taken by mouth, which is a more convenient treatment for newborns and young children compared to regular injections of insulin. 
To zdravilo je suspenzija, ki se zaužije, kar je za novorojenčke in majhne otroke primernejše od rednih injekcij insulina.
The attending specialist should then be contacted. 
Nato je treba stopiti v stik z lečečim specialistom.
There is a risk of high blood sugar. 
Obstaja tveganje za visoke ravni sladkorja v krvi.
Prior to launch of Amglidia in each Member State, the Marketing Authorisation Holder (MAH) must agree the content and format of an educational material for Amglidia, including communication media, distribution modalities, and any other aspects of the programme, with the National Competent Authority. 
Pred začetkom uporabe zdravila AMGLIDIA v posamezni državi članici se mora imetnik dovoljenja za promet z zdravilom z nacionalnim pristojnim organom dogovoriti o vsebini in obliki izobraževalnega programa, vključno s komunikacijskim medijem, načini distribucije in vsemi drugimi vidiki programa.
One child had dyspepsia, which was considered related to the medicinal product. 
En otrok je imel dispepsijo, za katero se smatra, da je povezana z zdravilom.
• Patients and/or their caretakers should be explained that: They are prescribed a dose of Amglidia in mL according to their body weight. 
• Bolnikom in/ali skrbnikom je treba pojasniti, da: je odmerek zdravila AMGLIDIA v ml predpisan glede na njihovo telesno maso.
This must be followed by continuous infusion of more dilute glucose solution (10%) at the rate needed to maintain blood-glucose above 100 mg/dL (100 mg/dL = 5.5 mmol/L). 
Temu mora slediti neprekinjena infuzija bolj razredčene raztopine glukoze (10 %) v hitrosti, potrebni za ohranjanje ravni glukoze v krvi nad 100 mg/dl (100 mg/dl = 5,5 mmol/l).
The syringe is packed in a transparent bag. 
Brizga je zapakirana v prosojni vrečki;
Pharmacotherapeutic group: Drugs used in diabetes, sulphonylureas, ATC code: A10BB01 
Farmakoterapevtska skupina: Zdravila za zdravljenje diabetesa, sulfonilsečnine, oznaka ATC: A10BB01
Quinolone antibiotics 
Kinolonski antibiotiki
The symptoms of moderate hypoglycaemia, without loss of consciousness or neurological signs, must be completely corrected by taking sugar, adjusting the dose and/or changing dietary behaviour. 
Simptome zmerne hipoglikemije, brez izgube zavesti ali nevroloških znakov, je treba v celoti odpraviti z jemanjem sladkorja, prilagoditvijo odmerka in/ali spremembo prehranjevalnih navad.
It is recommended that such patients change treatment to insulin. 
Priporočljivo je, da take bolnice preidejo na zdravljenje z insulinom.
Neutropenia and transitory increased transaminases One child had punctually low leucocytes level, but close to the normal range (neutrophils 1.3×103/µL for a lower limit of normal of 1.5×103/µL). 
Nevtropenija in prehodno povišane ravni transaminaz En otrok je imel trenutno nizko raven levkocitov, vendar blizu normalnih vrednosti (nevtrofilci 1,3 x 103/µl, spodnja meja normalne vrednosti je 1,5 x 103/µl).
The bottle does not need to be shaken before administration. 
Steklenice pred uporabo ni treba pretresti.
- if your child is treated with bosentan, e.g. a medicine used to treat problems of blood circulation. 
- če se vaš otrok zdravi z bosentanom, npr. zdravilom, ki se uporablja za zdravljenje težav s krvnim obtokom;
Make sure you have the box containing the syringe size prescribed by your doctor. 
Preverite, ali imate škatlo, ki vsebuje brizgo velikosti, ki jo je predpisal zdravnik.
You should check capillary blood sugar of your child and follow the instructions described in section 4. 
Preverite raven sladkorja v krvi svojega otroka in sledite navodilom iz poglavja 4.
When limited to clinical trials or prospective data collections only, the average dose decreases to 0.2 to 0.3 mg/kg/day. 
Če podatke omejimo samo na klinična preskušanja ali prospektivne zbirke podatkov, se povprečni odmerek zmanjša na 0,2 do 0,3 mg/kg/dan.
Repeat the same protocol every week until insulin independence is achieved. 
Enak protokol ponavljajte vsak teden, dokler ne dosežete neodvisnosti od insulina.
There is a risk of hypoglycaemia. 
Obstaja tveganje za hipoglikemijo.
Glibenclamide crosses the placenta mostly in small amounts; however, transfer is highly variable among patients. 
Glibenklamid prehaja skozi placento večinoma v majhnih količinah, vendar se to prehajanje med bolnicami zelo razlikuje.
You should only use the syringe which has been prescribed by your doctor. 
Uporabljate lahko samo brizgo, ki jo je predpisal zdravnik.
Adrenaline (epinephrine) and other sympathomimetic agents 
Adrenalin (epinefrin) in drugi simpatikomimetiki
If a hypoglycaemic coma is diagnosed or suspected, the patient should quickly receive an intravenous injection of concentrated glucose solution (0.5 g/kg body weight as a 30% glucose solution). 
Če se diagnosticira hipoglikemična koma ali se sumi nanjo, mora bolnik hitro prejeti intravensko injekcijo koncentrirane raztopine glukoze (0,5 g/kg telesne mase v obliki 30 % raztopine glukoze).
In case of nausea glycaemia seems to be maintained and insulin does not need to be re-introduced until the patient is able to take the glibenclamide suspension. 
V primeru navzee se glikemija očitno ohranja, zato ni treba ponovno uvesti insulina, dokler lahko bolnik jemlje suspenzijo glibenklamida.
While the child is awake, position the child in half-sitting position in the hollow of your arm, with the child's head resting on your arm. 
Ko je otrok buden, ga v svojem naročju namestite v polsedeči položaj, tako da njegova glava počiva na vaši roki.
There were no reported episodes of severe hypoglycaemia. 
O epizodah hude hipoglikemije niso poročali.
To avoid exceeding sodium benzoate acceptable daily dose, AMGLIDIA daily dose should not exceed 1 mL/kg/day. 
Za preprečitev prekoračitve sprejemljivega dnevnega odmerka natrijevega benzoata dnevni odmerek zdravila AMGLIDIA ne sme preseči 1 ml/kg/dan.
Repeat the same protocol every day until insulin independence is achieved. 
Enak protokol ponavljajte vsak dan, dokler ne dosežete neodvisnosti od insulina.
If at the end of a 5 to 6-week period, there is no evidence of a response with insulin doses similar to those at starting, administration of doses up to 2 mg/kg/day for a week may be tried. 
Če ob koncu pet- do šesttedenskega obdobja ni dokazov o odzivu pri odmerkih insulina, podobnih tistim na začetku, se lahko poskusi z enotedenskim dajanjem odmerkov do 2 mg/kg/dan.